Results 191 to 200 of about 65,332 (276)

The Cellular Response Capacity as Diagnostic Head Start in Neutrophil Endotoxemia Sensing

The FASEB Journal, Volume 40, Issue 10, 31 May 2026.
This study introduces the neutrophil cellular response capacity (CRC), a flow‐cytometry‐based approach for detecting prior endotoxin exposure across the inflammatory continuum in human whole blood. By comparing baseline and ex vivo restimulated neutrophil marker expression, the CRC identified low‐dose LPS exposure with greater analytical sensitivity ...
David Alexander Christian Messerer, Adam Omar Khalaf Mohamed, Lisa Wohlgemuth, Laura Vidoni, Christiane Leonie Knapp, Paul Müller, Bertram Dietrich Thomaß, Karl Föhr, Eberhard Barth, Manfred Weiss, Bettina Jungwirth, Kristina Nilsson Ekdahl, Bo Nilsson, Markus Huber‐Lang   +13 more
wiley   +1 more source

A Case of Severe Prekallikrein Deficiency Manifesting as Isolated Activated Partial Thromboplastin Time (aPTT) Prolongation. [PDF]

Cureus
Viswanathan D, Sivanandam A, Yeung V.
europepmc   +1 more source

A Recurrent Neural Network Model for Predicting Activated Partial Thromboplastin Time After Treatment With Heparin: Retrospective Study. [PDF]

JMIR Med Inform, 2022
Boie SD, Engelhardt LJ, Coenen N, Giesa N, Rubarth K, Menk M, Balzer F.   +6 more
europepmc   +1 more source

Algorithm-based effective recognition of acquired hemophilia A and other causes of isolated prolonged activated partial thromboplastin time within large blood sample series. [PDF]

Res Pract Thromb Haemost
Turincev P, Gomez F, Coutaz C, Quarroz S, Alberio L, Rufer N.   +5 more
europepmc   +1 more source

Interference of C-reactive protein with clotting times [PDF]

, 2015
De Bisschop, Frank, Delanghe, Joris, Devreese, Katrien, Verfaillie, Charlotte   +3 more
core   +1 more source

Dynamic changes of activated partial thromboplastin time and correlation with mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study. [PDF]

PLoS Negl Trop Dis
Wang H, Fang S, Wang H, Zheng X.
europepmc   +1 more source

Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study. [PDF]

Kidney Med
Wang LS, Ertmann E, Feldman E, Kossoff M, Lu B, Lin JC, Pishko A, Redfield R, Leonberg-Yoo A, Cuker A.   +9 more
europepmc   +1 more source

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy [PDF]

, 2015

core   +1 more source

A prolonged activated partial thromboplastin time indicates poor short-term prognosis in patients with hepatic encephalopathy: insights from the MIMIC database. [PDF]

Front Med (Lausanne)
Zhan L, Yang Y, Nie B, Kou Y, Du S, Tian Y, Huang Y, Ye R, Huang Z, Luo B, Ge L, Ye S.   +11 more
europepmc   +1 more source

Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation. [PDF]

Clin Appl Thromb Hemost
Burša F, Frelich M, Sklienka P, Němcová S, Kučerová Z, Jor O, Romanová T, Kondé A, Janošek J, Sagan J, Máca J.   +10 more
europepmc   +1 more source